Dishman Carbogen Amcis Subsidiary Clears US FDA Inspection with Zero Observations
Dishman Carbogen Amcis Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 10:01 pm
Dishman Carbogen Amcis Subsidiary Clears US FDA Inspection with Zero Observations Dishman Carbogen Amcis Limited announced that its wholly owned subsidiary, CARBOGEN AMCIS AG, has successfully completed its maiden US FDA inspection at its manufacturing facility in Vionnaz, Switzerland. The regulatory audit concluded on 11th Sep'26 with zero observations and no issuance of Form 483, reaffirming strong compliance and quality standards across the company's global manufacturing footprint.
Original exchange filing (PDF)
More announcements from Dishman Carbogen Amcis Ltd
- The audio recording of Conference Call arranged by the Company with Investors on Monday, 16th November, 2026 which was commenced at 15:00 hrs. (IST) to discuss the financial result and .... 路 16 Nov 2026
- Pls. find enclosed herewith Investor Presentation. 路 16 Nov 2026
- Please find attached herewith Unaudited Financial Results for the Second Quarter and Half Year ended on 30/09/2026. 路 14 Nov 2026
- Dishman Carbogen Amcis Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 14 Nov 2026
- Please find attached herewith Unaudited Financial Results and Statutory Auditors Limited Review Report for the Second Quarter and Half Year ended on 30/09/2026. 路 14 Nov 2026
- Pls. find enclosed herewith intimation of Conference Call to be held on 16th November 2026. 路 16 Nov 2026
- DISHMAN CARBOGEN AMCIS LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 路 13 Nov 2026
